UTHR — United Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $22.91bn
- $19.99bn
- $3.18bn
Annual cashflow statement for United Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 476 | 727 | 985 | 1,195 | 1,335 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 247 | 165 | 37.8 | 120 | 150 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -174 | -141 | -97.8 | -60.2 | -107 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 598 | 803 | 978 | 1,327 | 1,561 |
| Capital Expenditures | -121 | -139 | -230 | -247 | -526 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -366 | -673 | -489 | 664 | -25.3 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -487 | -812 | -720 | 417 | -551 |
| Financing Cash Flow Items | -10.8 | -18.9 | -16.5 | -14.9 | -33.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 44.8 | 75.4 | -11.9 | -1,255 | -1,150 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 156 | 66.4 | 247 | 490 | -140 |